| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1448926
[patent_doc_number] => 06455046
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Use of mCRP to enhance immune responses'
[patent_app_type] => B1
[patent_app_number] => 09/567954
[patent_app_country] => US
[patent_app_date] => 2000-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7663
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455046.pdf
[firstpage_image] =>[orig_patent_app_number] => 09567954
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/567954 | Use of mCRP to enhance immune responses | May 8, 2000 | Issued |
| 09/560365 | Novel polynucleotides expressed in activated T-lymphocytes and proteins encoded thereby | Apr 27, 2000 | Abandoned |
Array
(
[id] => 1601870
[patent_doc_number] => 06476211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Methods and materials relating to CD39-like polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/557800
[patent_app_country] => US
[patent_app_date] => 2000-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 49599
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/476/06476211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09557800
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/557800 | Methods and materials relating to CD39-like polypeptides | Apr 24, 2000 | Issued |
Array
(
[id] => 1375895
[patent_doc_number] => 06562943
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Peptide epitopes recognized by disease promoting CD4 T lymphocytes'
[patent_app_type] => B1
[patent_app_number] => 09/552802
[patent_app_country] => US
[patent_app_date] => 2000-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21238
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562943.pdf
[firstpage_image] =>[orig_patent_app_number] => 09552802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/552802 | Peptide epitopes recognized by disease promoting CD4 T lymphocytes | Apr 19, 2000 | Issued |
Array
(
[id] => 1361909
[patent_doc_number] => 06565848
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Cadherin-like asymmetry protein-1, and methods for its use'
[patent_app_type] => B1
[patent_app_number] => 09/546934
[patent_app_country] => US
[patent_app_date] => 2000-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 31772
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/565/06565848.pdf
[firstpage_image] =>[orig_patent_app_number] => 09546934
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/546934 | Cadherin-like asymmetry protein-1, and methods for its use | Apr 10, 2000 | Issued |
Array
(
[id] => 1212532
[patent_doc_number] => 06709864
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-23
[patent_title] => 'Adipogenic differentiation of human mesenchymal stem cells'
[patent_app_type] => B1
[patent_app_number] => 09/537003
[patent_app_country] => US
[patent_app_date] => 2000-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 38
[patent_no_of_words] => 8898
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/709/06709864.pdf
[firstpage_image] =>[orig_patent_app_number] => 09537003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/537003 | Adipogenic differentiation of human mesenchymal stem cells | Mar 27, 2000 | Issued |
| 09/534966 | Single chain class I major histocompatibility complexes, constructs encoding same and methods of generating same | Mar 26, 2000 | Abandoned |
Array
(
[id] => 7643753
[patent_doc_number] => 06429287
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/495562
[patent_app_country] => US
[patent_app_date] => 2000-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6132
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/429/06429287.pdf
[firstpage_image] =>[orig_patent_app_number] => 09495562
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/495562 | Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof | Jan 31, 2000 | Issued |
Array
(
[id] => 1523264
[patent_doc_number] => 06352723
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Brain-derived alkali-soluble immunoregulatory composition'
[patent_app_type] => B1
[patent_app_number] => 09/494978
[patent_app_country] => US
[patent_app_date] => 2000-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 6523
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/352/06352723.pdf
[firstpage_image] =>[orig_patent_app_number] => 09494978
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/494978 | Brain-derived alkali-soluble immunoregulatory composition | Jan 30, 2000 | Issued |
Array
(
[id] => 4240325
[patent_doc_number] => 06166186
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma'
[patent_app_type] => 1
[patent_app_number] => 9/480784
[patent_app_country] => US
[patent_app_date] => 2000-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11563
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166186.pdf
[firstpage_image] =>[orig_patent_app_number] => 480784
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/480784 | Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma | Jan 9, 2000 | Issued |
| 09/479508 | Expression and export of anti-obesity proteins as Fc fusion proteins | Jan 6, 2000 | Abandoned |
Array
(
[id] => 1483810
[patent_doc_number] => 06365155
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same'
[patent_app_type] => B1
[patent_app_number] => 09/446983
[patent_app_country] => US
[patent_app_date] => 1999-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5071
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365155.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446983
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446983 | Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same | Dec 29, 1999 | Issued |
| 09/446464 | PEPTIDES DERIVED FROM COMPLEMENT PEPTIDE C3A SEQUENCE AND ANTIALLERGIC COMPOSITIONS COMPRISING THEM | Dec 21, 1999 | Abandoned |
| 09/465321 | METHOD AND APPARATUS FOR THE PRODUCTION OF SOLUBLE MHC ANTIGENS | Dec 16, 1999 | Abandoned |
Array
(
[id] => 1596084
[patent_doc_number] => 06384190
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Isolated decapeptides which bind to HLA molecules'
[patent_app_type] => B1
[patent_app_number] => 09/461083
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7066
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384190.pdf
[firstpage_image] =>[orig_patent_app_number] => 09461083
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/461083 | Isolated decapeptides which bind to HLA molecules | Dec 13, 1999 | Issued |
Array
(
[id] => 7636702
[patent_doc_number] => 06379953
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Ligands that modulate differentiation of mesenchymal stem cells'
[patent_app_type] => B1
[patent_app_number] => 09/452142
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 8266
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/379/06379953.pdf
[firstpage_image] =>[orig_patent_app_number] => 09452142
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/452142 | Ligands that modulate differentiation of mesenchymal stem cells | Nov 30, 1999 | Issued |
Array
(
[id] => 4364416
[patent_doc_number] => 06274329
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Method for the detecting thyroid autoantibodies'
[patent_app_type] => 1
[patent_app_number] => 9/380732
[patent_app_country] => US
[patent_app_date] => 1999-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3836
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274329.pdf
[firstpage_image] =>[orig_patent_app_number] => 380732
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380732 | Method for the detecting thyroid autoantibodies | Nov 22, 1999 | Issued |
| 09/443638 | Inhibition therapy for septic shock with mutant cd14 | Nov 17, 1999 | Abandoned |
Array
(
[id] => 1490590
[patent_doc_number] => 06417165
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'NY-ESO-1-peptide derivatives, and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/440621
[patent_app_country] => US
[patent_app_date] => 1999-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6376
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417165.pdf
[firstpage_image] =>[orig_patent_app_number] => 09440621
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/440621 | NY-ESO-1-peptide derivatives, and uses thereof | Nov 14, 1999 | Issued |
| 09/438136 | Method for the production of non-immunogenic proteins | Nov 9, 1999 | Abandoned |